Home/ Supplements/ Ginkgo/ T9 To T10 Adr

T9 To T10 Adr

product on market Capsule Chiro-Zyme Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains botanical extracts including Ginkgo biloba and Eleuthero, which are studied for cognitive support and adaptogenic properties. There is moderate evidence supporting the use of Ginkgo for memory and Gotu Kola for circulation. Overall, research on the combined efficacy of these specific ingredients is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for T9 To T10 Adr
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

vegetarian Yeast
150 mg
Eleuthero
150 mg
Gotu Kola
100 mg
Rose Hip
60 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Wild Yam (Dioscorea villosa) (root) extract
10 mg
Proprietary Plant Enzyme Blend
111 mg

Other Ingredients

Vegetable Capsule Phytase
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: Take 2 capsules, 3 times daily between meals or as directed.

Warnings & Precautions

Keep out of reach of children

Note: Consult your physician before using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Do not use if inner or outer seal is broken, torn, or missing.

Additional Information

To ensure freshness and potency, keep bottle tightly closed and store in a cool, dry place.

J-64675-6

Metadata

Product Details

UPC / SKU6 97706 00101 3
DSLD Entry Date2018-04-25
Product TypeOther Combinations
FormCapsule
DSLD ID176396
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.